CTSD and neuroblastoma: Secomandi et al. have indicated that the overexpression of CTSD in neuroblastoma reduced the proliferation of tumor cells by down-regulating oncogenic MAPK signaling pathway, and the high expression of CTSD correlated with better prognosis [34].